Seeking endocrinologist in Santa Cruz

[RustyO]

Hi,

I already have a medical marijuana card, so that's not what I'm asking.

I'm diabetic, and the endocrinologist that I see on a regular basis is not pot-friendly. Thus, I'm looking for a doctor who can help me control my diabetes using glucose-lowering pharmaceuticals together with cannabis.

If you know of such a doctor, please let me know.

RustyO

RustyO Reviewed by RustyO on 06-18-2011. Seeking endocrinologist in Santa Cruz Hi, I already have a medical marijuana card, so that's not what I'm asking. I'm diabetic, and the endocrinologist that I see on a regular basis is not pot-friendly. Thus, I'm looking for a doctor who can help me control my diabetes using glucose-lowering pharmaceuticals together with cannabis. If you know of such a doctor, please let me know. RustyO Rating: 5

[Storm Crow]

Can't help you finding a new doctor, but I can help you educate your present one! Get a roll of stamps and send him a few of these every week! This is what cannabis does for diabetes!

Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes (abst - 2004)
Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes -- Liou et al. 45 (5): 860 -- ARVO Meeting Abstracts

The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
(abst â?? 2004)
The effect of WIN 55,212-2, a cannabinoid agonist,... [Neurosci Lett. 2004] - PubMed result

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
(full - 2005)
Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice

Activation of the Peripheral Endocannabinoid System in Human Obesity
(full - 2005)
Activation of the Peripheral Endocannabinoid System in Human Obesity

Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full - 2006)
Elsevier

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and Ã?-Pancreatic Cells and in Obesity and Hyperglycemia (full - 2006)
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and

Weight Control in Individuals With Diabetes (full - 2006)
Weight Control in Individuals With Diabetes

Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. (abst â?? 2006)
Changes in endocannabinoid and palmitoylethanolami... [Prostaglandins Leukot Essent Fatty Acids. 2006] - PubMed result

The Cannabinergic System as a Target for Anti-inflammatory Therapies
(abst - 2006)
ingentaconnect The Cannabinergic System as a Target for Anti-inflammatory Therap...

Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says
(news - 2006)
Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says - NORML

Marijuana Compound May Help Stop Diabetic Retinopathy (news - 2006)
Marijuana Compound May Help Stop Diabetic Retinopathy

Cannabidiol reduces the development of diabetes in an animal study
(news - 2006)
International Association for Cannabis as Medicine

Getting Eye On Cannabinoids (news - 2006)
Getting Eye On Cannabinoids: The Hempire - [cannabis, hemp]

Marijuana compound could prevent eye damage in diabetics (news - 2006)
Marijuana compound could prevent eye damage in diabetics: The Hempire - [cannabis, hemp]

Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention (news â?? 2006)
Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention ( A compound in marijuana has been found ...)

Cannabidiol arrests onset of autoimmune diabetes in NOD mice (full - 2007)
http://safeaccess.ca/research/pdf/We...cology2007.pdf

Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy
(full - 2007)
Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy

Cannabidiol attenuates high-induced endothelial cell inflammatory response and barrier disruption (full - 2007)
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells (abst - 2007)
The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells.

Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model (abst - 2007)
Anticoagulant effects of a Cannabis extract in an obese rat model.

Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full - 2008)
Obesity - Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet

Endocannabinoids and the Control of Energy Homeostasis (full â?? 2008)
Endocannabinoids and the Control of Energy Homeostasis

Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full - 2008)
Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor*

The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids (full â?? 2008)
The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids

GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008)
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity

Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. (full - 2008)
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation

Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full â?? 2008)
http://www.iovs.org/content/49/12/5526.full

Presence of functional cannabinoid receptors in human endocrine pancreas. (abst â?? 2008)
Presence of functional cannabinoid receptors in hu... [Diabetologia. 2008] - PubMed result

Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full - 2009)
Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development

Cannabinoids as novel anti-inflammatory drugs. (full - 2009)
Cannabinoids as novel anti-inflammatory drugs

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full - 2009)
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis

The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant (full - 2009)
The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant

Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes (abst - 2009)
Unbound MEDLINE | Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes. PubMed Journal article abstract

Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. (abst â?? 2009)
Anti-inflammatory effect of palmitoylethanolamide ... [Obesity (Silver Spring). 2009] - PubMed result

Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress. (abst - 2009)
Unbound MEDLINE | Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. PubMed Journal article abstract

Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news â?? 2009)
Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug, the scientist who developed a former world-beating treatment for the condition believes. - Free Online Library

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
(full - 2010)
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy (full â?? 2010)
http://diabetes.diabetesjournals.org...c-4aec5dfac384

Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full â?? 2010)
http://content.karger.com/ProdukteDB...ame=320527.pdf

Expression and function of cannabinoid receptors in mouse islets. ( full â?? 2010)
http://www.landesbioscience.com/jour...iISLETS2-5.pdf

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients (full - 2010)
Lipids in Health and Disease | Full text | Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients

Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.
(full â?? 2010)
Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010)
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. (full - 2010)
Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
(abst - 2010)
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy -- Rajesh et al. 56 (25): 2115 -- Journal of the American College of Cardiology

GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst â?? 2010)
GPR119 agonists for the potential treatment of typ... [Vitam Horm. 2010] - PubMed result

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst â?? 2010)
Novel GPR119 agonist AS1535907 contributes to firs... [Biochem Biophys Res Commun. 2010] - PubMed result

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst â?? 2010)
AS1907417, a novel GPR119 agonist, as an insulinot... [Biochem Biophys Res Commun. 2010] - PubMed result

Pot Compound Mitigates Diabetic Cardiomyopathy (news - 2010)
Pot Compound Mitigates Diabetic Cardiomyopathy - NORML

Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (news - 2010)
MediGardens: March 2010: Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (University of Calgary; Alberta, Canada)

Lab Notes: Pot Has Benefits for Diabetic Hearts (news - 2010)
Medical News: Lab Notes: Pot Has Benefits for Diabetic Hearts - in Lab Notes, Lab Notes from MedPage Today

Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (abst â?? 2011)
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis

Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells (abst â?? 2011)
Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic

Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. (abst â?? 2011)
Unbound MEDLINE | Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. PubMed Journal article abstract

Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes.
(abst â?? 2011)
Unbound MEDLINE | Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes. PubMed Journal article abstract

Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. (abst â?? 2011)
Unbound MEDLINE | Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. PubMed Journal article abstract

GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (abst â?? 2011)
GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms

Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst - 2011)
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation -- Liou et al. 52 (6): 1002 -- ARVO Meeting Abstracts

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (abst â?? 2011)
Cannabidiol as an emergent therapeutic strategy fo... [Free Radic Biol Med. 2011] - PubMed result


Hope it works!

Granny

[cannapro]

What an amazing collection of information - thank you so much for that!!!

[Jackwidow420]

Hey RustyO did you find any one?

[painretreat]

JW, I think Rusty O is busy edumacating his doktor with the wealth of information he was given to mail his Doc! Or, he is still digesting all the posible cures mmj is for his condition. Hope you aren't in a coma RO. Could be a longtime before we hear from him again! Will be nice to know if he was able to sway his doc!

Just off the cuff, I am betting there aren't very many endocrinologists in that area and he may have to go to another city if he cannot sway his present doc. pr

[RustyO]

Hi folks,

As I wrote in my initial post, my endocrinologist is not pot-friendly. Besides, the entire clinic, where the doctor practices, is not pot-friendly. I'm not too enthused about teaching an old doc a new trick. You'd think that, n a pro-cannabis town like Santa Cruz, there'd be doctors who are willing to treat diabetes with pot.

Thanks for the info you've all provided.

RustyO